Brief: Aurobindo Pharma Receives USFDA Approval For Glycerol Phenylbutyrate Oral Liquid, 1.1 Grams Per Ml
17/04/2026 06:09
April 17 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: RECEIVES USFDA APPROVAL FOR GLYCEROL PHENYLBUTYRATE ORAL LIQUID, 1.1 GRAMS PER ML TO LAUNCH GLYCEROL PHENYLBUTYRATE ORAL LIQUID IMMEDIATELY Source text: ID:nBSE8FZb3T Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11